Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
19-Aug-2026 | 360 | 362.95 | 354.5 | 356.05 | 2,196 | 3,67,81,150.95 | 67,297 |
20-Aug-2026 | 357.5 | 364.15 | 355 | 356.5 | 2,213 | 4,01,27,975.9 | 69,084 |
21-Aug-2026 | 357 | 358.75 | 351 | 356.6 | 3,135 | 4,62,00,280.15 | 74,461 |
24-Aug-2026 | 358.1 | 362 | 353.5 | 354.1 | 3,362 | 5,00,99,038.05 | 84,129 |
25-Aug-2026 | 354.15 | 358.9 | 350.4 | 356.75 | 3,968 | 6,05,42,770.05 | 96,110 |
26-Aug-2026 | 357 | 360.85 | 354.15 | 357.7 | 2,212 | 2,98,66,466.15 | 51,571 |
27-Aug-2026 | 359.2 | 363.85 | 354.1 | 362.45 | 3,576 | 5,53,68,883.8 | 87,839 |
28-Aug-2026 | 363.15 | 363.15 | 349.25 | 355.55 | 3,513 | 4,74,39,839 | 75,495 |
31-Aug-2026 | 354.05 | 378.5 | 350.55 | 371.85 | 9,904 | 17,01,80,159 | 2,23,777 |
01-Sep-2026 | 374.2 | 374.2 | 366.3 | 368.25 | 2,469 | 3,05,89,746.7 | 43,531 |
02-Sep-2026 | 367 | 376 | 362.1 | 373.05 | 5,466 | 6,55,65,848.4 | 76,533 |
03-Sep-2026 | 373.05 | 376.4 | 368.55 | 374.15 | 1,774 | 2,14,66,009.7 | 31,049 |
04-Sep-2026 | 374 | 398.4 | 373 | 392.5 | 11,260 | 18,42,07,087.8 | 1,91,678 |
07-Sep-2026 | 390 | 444 | 387.45 | 397.95 | 72,833 | 1,62,06,96,208.05 | 8,03,535 |
08-Sep-2026 | 402.7 | 409.4 | 394.15 | 399.15 | 15,389 | 25,40,12,841.5 | 2,58,807 |
09-Sep-2026 | 405 | 417.7 | 402.05 | 407.3 | 16,910 | 21,43,11,722.65 | 1,80,688 |
10-Sep-2026 | 410.55 | 421 | 407 | 417.45 | 16,198 | 23,26,32,918.6 | 2,19,805 |
11-Sep-2026 | 417.85 | 469 | 414.55 | 463.45 | 2,37,234 | 4,71,04,48,446.95 | 15,02,891 |
15-Sep-2026 | 477.95 | 482 | 397.5 | 410.15 | 1,05,763 | 1,81,74,68,387.45 | 12,86,644 |
16-Sep-2026 | 410.2 | 413.35 | 393.25 | 402.95 | 23,718 | 32,26,41,050.75 | 2,01,625 |
17-Sep-2026 | 405.25 | 418.55 | 403.25 | 413.75 | 17,903 | 27,80,74,310.7 | 2,36,113 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
